Synageva (GEVA) Prices 3.11M Offering at $25.18/Share
Tweet
Share
E-mailGet Alerts GEVA Hot Sheet
Join SI Premium – FREE
Synageva BioPharma Corp. (Nasdaq: GEVA), has priced its previously announced underwritten public offering of common stock consisting of 3,108,057 shares at $25.18 per share.
In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase 466,209 additional shares of common stock to cover over-allotments, if any.
In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase 466,209 additional shares of common stock to cover over-allotments, if any.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Momentus terminates $50M equity purchase agreement with Yield Point NY
- Southern Cross Acquisition II prices $75M IPO on Nasdaq
- Morningstar Q&A: AI Pricing, PitchBook Growth and Private Markets
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
